نبذة مختصرة : Background: Liver transplant recipients are at greater risk of both maternal and fetal complications than healthy parturients. Methods: In this retrospective study, we looked at the case files of liver transplant recipients who came for safe confinement from 2011 to 2021. Patients’ demography, transplant details, immunosuppressive regimen, pregnancy information, maternal complication, graft function, and fetal outcomes were examined. Results: A total of 12 liver recipients were delivered in this institute during this time interval. All patients had live-related liver transplants; the mean transplantation delivery interval was 4.8 years. They were all on immunosuppressant medications. Of the patients, 75% had elective cesarean delivery, which was performed under subarachnoid block. In addition, 66.7% (two-thirds) of patients who delivered vaginally had epidural analgesia. There were no severe intraoperative or postoperative maternal anesthetic complications. None of the patients had graft rejection or significant deterioration in liver function tests. Three babies (25%) were delivered preterm. One of the fetuses was stillborn. All others had an Apgar score of 9 at 5 min and did not require any intensive care unit stay. Conclusion: Pregnancy in liver transplant recipients should undergo safe confinement in a tertiary care center under the care of a multidisciplinary team including a hepatologist, transplant surgeon, obstetrician, neonatologist, and obstetric anesthesiologist. Despite the apprehension, planned pregnancies in these parturients have a good obstetric and neonatal outcome. These patients can safely undergo a lower segment cesarean section under regional anesthesia or receive labor epidural analgesia for a vaginal delivery with minimal risk of complications.
Processing Request
No Comments.